NCT06809634 Large Linguistic Model for Clinical Reaoning of Physical Therapy Students
| NCT ID | NCT06809634 |
| Status | Recruiting |
| Phase | Phase 2 |
| Sponsor | Neuron, Spain |
| Condition | Healthy |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2023-09-01 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
In Phase 2, researchers evaluate early signs of effectiveness. You may be randomized to receive the active treatment or a comparator. Monitoring continues closely.
This trial targets 60 participants in total. It began in 2023-09-01 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Clinical reasoning is a fundamental skill for physical therapy students, enabling them to collect and interpret patient information to make accurate diagnoses and treatment decisions. Traditional training methods often limit students' exposure to a diverse range of clinical cases, which can restrict the development of these skills. The integration of Large Language Models (LLMs), such as ChatGPT, into physical therapy education offers a novel approach to enhance clinical reasoning by simulating interactive and realistic patient scenarios. This randomized controlled trial aims to evaluate the effectiveness of an LLM-based educational intervention in improving clinical reasoning skills in physical therapy students. The study will recruit a total of 200 third-year physiotherapy students from multiple university institutions. Participants will be randomly assigned to one of two groups: 1. Experimental Group - Students will receive LLM-based training, engaging with a conversational artificial intelligence model to solve clinical cases over an 8-week period. The model will provide real-time responses to their questions, allowing them to refine their diagnostic and treatment reasoning. 2. Control Group - Students will follow the standard curriculum, participating in conventional case-based learning and supervised clinical reasoning exercises without AI-based assistance. The primary outcome of the study is the improvement in clinical reasoning skills, assessed through standardized written case evaluations and structured practical examinations. Secondary outcomes include changes in digital competence, student engagement levels, overall satisfaction with the educational approach, and cost-effectiveness of the intervention. By assessing the impact of LLMs on clinical reasoning training, this study seeks to determine whether AI-driven educational tools can effectively complement traditional physiotherapy education and improve student preparedness for real-world clinical practice.
Eligibility Criteria
Inclusion Criteria: * Students enrolled in the third year of the Physiotherapy program at La Salle Centre for Higher University Studies (LCHUS) * Participants must be between 18 and 30 years old. * Students must agree to participate in the study by signing an informed consent form after being briefed about the study's objectives, procedures, and potential risks. * Participants must be willing to engage with the LLM-based platform (for the experimental group) or participate in traditional learning activities (for the control group) for the duration of the study. Exclusion Criteria: * Students with previous clinical experience beyond the third year of physiotherapy education. * Physical or cognitive disabilities that may interfere with the ability to participate in or benefit from the intervention (e.g., vision, hearing, or motor impairments). * Students who do not provide informed consent to participate in the study. * Students who do not possess sufficient proficiency in Spanish or English to understand the materials and the intervention.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06809634 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 30 Years, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT06809634 trial and what does that mean for participants?
Phase 2 trials evaluate whether the treatment shows signs of effectiveness while continuing to monitor safety. More participants are enrolled than in Phase 1 to help refine the treatment protocol.
Is NCT06809634 currently recruiting?
Yes, NCT06809634 is actively recruiting participants. Contact the research team at alfredo.lerin@lasallecampus.es for enrollment information.
Where is the NCT06809634 trial being conducted?
This trial is being conducted at Madrid, Spain.
Who is sponsoring the NCT06809634 clinical trial?
NCT06809634 is sponsored by Neuron, Spain. The trial plans to enroll 60 participants.